BioRestorative Therapies (NASDAQ:BRTX) focuses on developing products and therapies using cell and tissue protocols, primarily aimed at addressing unmet medical needs. Their operations cover a broad spectrum of developmental projects, such as innovative treatments for metabolic disorders and disc/spine disease management through their ThermoStem® and brtxDISC™ programs. BioRestorative Therapies’ objective is to pioneer in the sphere of regenerative medicine by advancing these programs to commercial stages, thereby offering new therapeutic options to patients and the broader healthcare community. With a commitment to scientific excellence and innovation, the company seeks to improve the quality of life for individuals suffering from conditions that currently have limited treatment options.